Protalix Biotherapeutics Inc (PLX)
EBITDA Margin
28.95%
Quarterly · Period ending:
PLX EBITDA Margin
Latest reported28.95%period ending
Latest reported28.95%period ending
PLX Quarterly EBITDA Margin (0.00% → 28.95%)
Quarterly ebitda margin
High-resolution chart · PNG
PLX ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -6,504,700% | |
| 0% | |
| 0% | |
| -1,557,200% | |
| -7,780,500% | |
| -6,817,900% | |
| -179.5395% | |
| -246.4768% | |
| -12.8596% | |
| -0.5598% | |
| -28.0142% | |
| 3.1034% | |
| -0.431% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |